FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2834467 · Received November 15, 2012

Report

Report Number
2024168-2012-07230
Event Type
Injury
Date Received
November 15, 2012
Date of Event
April 1, 2012
Report Date
October 23, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WERE NO REPORTED PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECTS OF ANGINA AND STENOSIS/RESTENOSIS ARE LISTED IN THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE AS KNOWN ADVERSE EVENTS. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2008, A XIENCE V STENT WAS IMPLANTED IN A DISTAL, LEFT ANTERIOR DESCENDING ARTERY AND AT A FOLLOW UP VISIT, THE PATIENT STATED THAT IN (B)(6) 2012 HE PRESENTED TO THE EMERGENCY ROOM WITH CHEST PAINS [ANGINA] AND WAS DIAGNOSED WITH 70% IN STENT RESTENOSIS. TROPONIN ENZYME LEVELS AND TWO ELECTROCARDIOGRAMS WERE DONE WITH NO FINDINGS OF A MYOCARDIAL INFARCTION. AN ANGIOPLASTY WAS DONE TO THE PROXIMAL LEFT ANTERIOR DESCENDING ARTERY AND THE STENT PLACED IN THE DISTAL LAD. REVASCULARIZATION WAS ACHIEVED. THE PATIENT WAS STARTED ON EFFIENT MEDICATION. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 8052842

Patients

Seq Age Sex Outcome Treatment
1 57 YR Hospitalization| R